Non-alcoholic fatty liver disease can result in cirrhosis of the liver or liver cancer.
非酒精性脂肪肝病能够导致肝硬化或肝癌。
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
在非酒精性脂肪肝患者中，慢性肾病的风险：之间有联系吗？
This is one side of our better understanding in recent studies of non-alcoholic fatty liver disease.
这是我们对非酒精性脂肪肝理解更深入的一个方面。
Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver.
非酒精性脂肪肝被认为是肝的代谢综合症的表现。
I believe that when you look at non-alcoholic fatty liver disease you are dealing with a spectrum of different diseases.
我认为当我们在研究非酒精性脂肪肝时，我们面对的是不同疾病的疾病谱。
Dr. Younossi: I think there is a misunderstanding of non-alcoholic fatty liver disease in which subgroups would progress.
Younossi教授：我觉得对会进展的非酒精性脂肪肝存在误解。
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals.
【译】适量饮酒降低非酒精性脂肪性肝病的风险：43的175个人的荟萃分析。
AIM: to explore the effects of silybin on mitochondrial membrane fluidity in the rats with non-alcoholic fatty liver disease (NAFLD).
目的：探讨非酒精性脂肪性肝病(NAFLD)大鼠模型中肝脏线粒体膜流动性的改变以及观察水飞蓟宾对NAFLD的防治作用。
Objective To observe the effect of herbal recipe Zhiganqing capsule (ZGQ capsule) in treating non-alcoholic fatty liver disease (NAFLD).
目的观察脂肝清胶囊对非酒精性脂肪性肝病的疗效。
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
【译】适度饮酒与非酒精性脂肪肝患者脂肪肝(NAFLD)的患病率下降有关的。
In contrast, EPA offered only partial protection against CLA-induced non-alcoholic fatty liver disease and provided no protection against insulin resistance.
相比之下，EPA只是提供了部分性的保护作用预防CLA诱导的非酒精性脂肪肝病，而对胰岛素抵抗未提供保护作用。
In fact, interleukin-1 in this scenario can induce fat deposition in the hepatocytes which is one of the characteristics on non-alcoholic fatty liver disease.
事实上，白细胞介素- 1在这种情况下可以诱导肝细胞脂肪沉积，这是非酒精性脂肪性肝病的一个特征。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.
我们及其他研究者最近得出的这一结论适用于多种肝脏疾病，包括乙型慢性病毒性肝炎、丙型慢性病毒性肝炎、酒精性肝病和非酒精性脂肪肝。
Still, she says, her research suggests that with respect to long-term survival of people with non-alcoholic fatty liver disease, "it may not matter if you have the disease or not."
尽管如此，她说，她的研究表明，关于非酒精性脂肪肝病患者的长期存活率，“也许与你有或没有这个疾病无关。”
We were surprised to say the least because we expected to learn by how much non-alcoholic fatty liver disease increased the risk of death and instead found the answer was not at all.
退一步说我们很惊讶，因为我们预期想得到脂肪肝疾病在多大程度上增加死亡风险的，而发现答案是根本不增加。
Objective It is to discuss the effect, safety and practicality of equilibrium therapy of decontamination living creature of blood dilution(ETBD) on non-alcoholic fatty liver disease(NAFLD).
目的探讨血液稀释净化生物平衡疗法（ETBD）治疗非酒精性脂肪肝（NAFLD）的效果、安全性、实用性。
Results The prevalence of fatty liver disease was 26.8% in which 18.1% was non-alcoholic and 8.7% was alcoholic. There was no significant difference between male and female.
结果脂肪肝患病率为26.8%，其中非酒精性脂肪肝患病率18.1%，酒精性脂肪肝患病率8.7%，男女脂肪肝患病率差异无显著性。
Results The prevalence of fatty liver disease was 26.8% in which 18.1% was non-alcoholic and 8.7% was alcoholic. There was no significant difference between male and female.
结果脂肪肝患病率为26.8%，其中非酒精性脂肪肝患病率18.1%，酒精性脂肪肝患病率8.7%，男女脂肪肝患病率差异无显著性。
应用推荐